Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Scientists find gene signature for poor response to standard therapy in rare uterine cancer

Women who don't survive a rare and aggressive uterine cancer called uterine serous carcinoma, have high expression of a group of 73 genes, a score scientists say can help identify these women and improve their outcome.